• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性和非酒精性脂肪性肝炎中的细胞凋亡

Apoptosis in alcoholic and nonalcoholic steatohepatitis.

作者信息

Feldstein Ariel E, Gores Gregory J

机构信息

Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, OH, USA.

出版信息

Front Biosci. 2005 Sep 1;10:3093-9. doi: 10.2741/1765.

DOI:10.2741/1765
PMID:15970563
Abstract

Alcohol liver disease (ALD) as well as nonalcoholic fatty liver disease (NAFLD) are two of the most common forms of chronic liver disease worldwide and may progress to cirrhosis and end stage liver disease. ALD and NAFLD seem to share many pathophysiologic mechanisms with the accumulation of lipids in the liver being the first step in the development of both conditions. While mitochondrial dysfunction and production of reactive oxygen species seem to play an important role in the progression from simple steatosis to steatohepatitis in both diseases, the pathogenesis of ALD and NAFLD as it relates to tissue injury remains poorly understood. Insights into these mechanisms are of significant clinical importance because current therapies for both conditions are limited and future therapies will be predicated by an understanding of their pathogenesis. In this review we focused on the current evidence for a central role of hepatocellular apoptosis, a specific form of cell death, in the pathogenesis of ALD and NAFLD as well as the current knowledge regarding the subcellular and molecular mechanisms involve in triggering hepatocyte apoptosis in these diseases.

摘要

酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)是全球最常见的两种慢性肝病形式,可能进展为肝硬化和终末期肝病。ALD和NAFLD似乎有许多共同的病理生理机制,肝脏中脂质的积累是这两种疾病发展的第一步。虽然线粒体功能障碍和活性氧的产生在这两种疾病从单纯性脂肪变性进展为脂肪性肝炎的过程中似乎起着重要作用,但ALD和NAFLD与组织损伤相关的发病机制仍知之甚少。深入了解这些机制具有重要的临床意义,因为目前针对这两种疾病的治疗方法有限,未来的治疗将取决于对其发病机制的理解。在这篇综述中,我们重点关注了肝细胞凋亡(一种特定形式的细胞死亡)在ALD和NAFLD发病机制中起核心作用的当前证据,以及目前关于这些疾病中触发肝细胞凋亡的亚细胞和分子机制的知识。

相似文献

1
Apoptosis in alcoholic and nonalcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎中的细胞凋亡
Front Biosci. 2005 Sep 1;10:3093-9. doi: 10.2741/1765.
2
Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎发病机制中的异同
Semin Liver Dis. 2009 May;29(2):200-10. doi: 10.1055/s-0029-1214375. Epub 2009 Apr 22.
3
Fibrosis in alcoholic and nonalcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎的纤维化。
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):231-44. doi: 10.1016/j.bpg.2011.02.010.
4
Genetics of alcoholic and nonalcoholic fatty liver disease.酒精性和非酒精性脂肪性肝病的遗传学。
Semin Liver Dis. 2011 May;31(2):128-46. doi: 10.1055/s-0031-1276643. Epub 2011 May 2.
5
Pathological features of fatty liver disease.脂肪肝疾病的病理特征。
Gastroenterology. 2014 Oct;147(4):754-64. doi: 10.1053/j.gastro.2014.07.056. Epub 2014 Aug 7.
6
Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.酒精性肝病/非酒精性脂肪性肝病指数:鉴别酒精性与非酒精性脂肪性肝病。
Eur J Gastroenterol Hepatol. 2013 Aug;25(8):899-904. doi: 10.1097/MEG.0b013e32835f0786.
7
Apoptosis and non-alcoholic fatty liver diseases.细胞凋亡与非酒精性脂肪性肝病。
World J Gastroenterol. 2018 Jul 7;24(25):2661-2672. doi: 10.3748/wjg.v24.i25.2661.
8
Autophagy in chronic liver diseases: the two faces of Janus.慢性肝病中的自噬:雅努斯的两面性。
Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C263-C273. doi: 10.1152/ajpcell.00295.2016. Epub 2016 Nov 30.
9
The epidemiology, pathogenesis and histopathology of fatty liver disease.脂肪性肝病的流行病学、发病机制和组织病理学。
Histopathology. 2012 Aug;61(2):141-52. doi: 10.1111/j.1365-2559.2011.04145.x. Epub 2012 Feb 28.
10
Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.非酒精性和酒精性脂肪性肝炎患者肝脏中的肝细胞凋亡、死亡受体表达及核因子κB激活
Am J Gastroenterol. 2004 Sep;99(9):1708-17. doi: 10.1111/j.1572-0241.2004.40009.x.

引用本文的文献

1
MetALD: Clinical aspects, pathophysiology and treatment.线粒体酒精性肝病:临床特征、病理生理学及治疗
JHEP Rep. 2024 Nov 2;7(2):101250. doi: 10.1016/j.jhepr.2024.101250. eCollection 2025 Feb.
2
Immunology and treatments of fatty liver disease.脂肪肝疾病的免疫学与治疗方法
Arch Toxicol. 2025 Jan;99(1):127-152. doi: 10.1007/s00204-024-03920-1. Epub 2024 Dec 18.
3
Pursh extract ameliorates hepatic steatosis by suppressing pyroptosis via the NLRP3/Caspase-1/GSDMD pathway.朴尔提取物通过NLRP3/半胱天冬酶-1/ Gasdermin D途径抑制细胞焦亡来改善肝脂肪变性。
Food Sci Nutr. 2024 Apr 16;12(7):5176-5187. doi: 10.1002/fsn3.4165. eCollection 2024 Jul.
4
Emricasan for the treatment of liver cirrhosis: a meta-analysis of randomized controlled trials.恩西地平治疗肝硬化的疗效:一项随机对照试验的荟萃分析。
Afr Health Sci. 2023 Jun;23(2):402-408. doi: 10.4314/ahs.v23i2.46.
5
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?酒精性肝病和肝细胞癌中的微小RNA:迈向新治疗方法的一步?
Cancers (Basel). 2023 Nov 23;15(23):5557. doi: 10.3390/cancers15235557.
6
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.酒精性肝病与非酒精性脂肪性肝病的交集。
Nat Rev Gastroenterol Hepatol. 2023 Dec;20(12):764-783. doi: 10.1038/s41575-023-00822-y. Epub 2023 Aug 15.
7
Role of ERK1/2 Signaling in Cinnabarinic Acid-Driven Stanniocalcin 2-Mediated Protection against Alcohol-Induced Apoptosis.ERK1/2 信号通路在肉桂酸诱导的 STC2 介导的抗酒精诱导细胞凋亡中的作用。
J Pharmacol Exp Ther. 2023 Oct;387(1):111-120. doi: 10.1124/jpet.123.001670. Epub 2023 Aug 10.
8
Alcohol-related hepatitis: A review article.酒精性肝炎:一篇综述文章。
World J Gastroenterol. 2023 May 7;29(17):2551-2570. doi: 10.3748/wjg.v29.i17.2551.
9
Emerging targets for therapy in ALD: Lessons from NASH.ALD 治疗的新兴靶点:来自 NASH 的经验。
Hepatology. 2024 Jul 1;80(1):223-237. doi: 10.1097/HEP.0000000000000381. Epub 2023 Mar 21.
10
Effect of 32-Weeks High-Intensity Interval Training and Resistance Training on Delaying Sarcopenia: Focus on Endogenous Apoptosis.32周高强度间歇训练和抗阻训练对延缓肌肉减少症的影响:聚焦内源性细胞凋亡
Front Physiol. 2022 Apr 28;13:811369. doi: 10.3389/fphys.2022.811369. eCollection 2022.